WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018029610) C-3 NOVEL TRITERPENONE WITH C-17 N-AMIDE DERIVATIVES AS HIV INHIBITORS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/029610    International Application No.:    PCT/IB2017/054858
Publication Date: 15.02.2018 International Filing Date: 09.08.2017
IPC:
C07J 53/00 (2006.01)
Applicants: HETERO LABS LIMITED [IN/IN]; Plot No B-80 & 81 A.P.I.E, Balanagar Hyderabad 500018 (IN)
Inventors: BANDI, Parthasaradhi Reddy; (IN).
KURA, Rathnakar Reddy; (IN).
GAZULA LEVI, David Krupadanam; (IN).
KASIREDDY, Bhaskar Reddy; (IN)
Priority Data:
201641027130 09.08.2016 IN
Title (EN) C-3 NOVEL TRITERPENONE WITH C-17 N-AMIDE DERIVATIVES AS HIV INHIBITORS
(FR) NOUVELLE TRITERPÉNONE EN C-3 AVEC DES DÉRIVÉS DE N-AMIDE EN C-17 EN TANT QU'INHIBITEURS DU VIH
Abstract: front page image
(EN)The present invention relates to C-3 novel triterpenone with C-17 N-amide compounds of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6 and 'X' are as defined in formula (I). The invention also relates to compounds of formula (I), its related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
(FR)La présente invention concerne un nouveau triterpénone en C-3 avec des composés de N-amide en C-17 de formule (I); et des sels pharmaceutiquement acceptables de celui-ci, dans laquelle R1, R2, R3, R4, R5, R6 et 'X' sont tels que définis dans la formule (I). La présente invention concerne également des composés de formule (I) et leurs composés apparentés, et des compositions pharmaceutiques utiles dans le traitement thérapeutique de maladies virales et en particulier de maladies induites par le VIH.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)